CO6260101A2 - Nuevos genes y proteinas de branchyspira hyodysenteriae y el uso de los mismos - Google Patents
Nuevos genes y proteinas de branchyspira hyodysenteriae y el uso de los mismosInfo
- Publication number
- CO6260101A2 CO6260101A2 CO10024772A CO10024772A CO6260101A2 CO 6260101 A2 CO6260101 A2 CO 6260101A2 CO 10024772 A CO10024772 A CO 10024772A CO 10024772 A CO10024772 A CO 10024772A CO 6260101 A2 CO6260101 A2 CO 6260101A2
- Authority
- CO
- Colombia
- Prior art keywords
- plasmid
- hyodysenteriae
- polynucleotide
- brachyspira
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Se describen el nuevo Polinucleótido y los aminoácidos de Brachyspira hyodysenteriae. Estas secuencias son útiles para el diagnóstico de la enfermedad de B. hyodysenteriae en animales y útiles como un tratamiento terapéutico o profiláctico de la enfermedad de B. hyodysenteriae en animales. Estas secuencias pueden también ser útiles para el diagnóstico y para el tratamiento terapéutico y/o profiláctico de enfermedades de los animales causada por Brachyspira en otras especies, incluyendo B. intermedia, B. suantatina, B.alvinipulli B. aalborgi, B.lnnocens, B.murdochii, y B. pilosicoli. 1.- Un polinucleótido que comprende la secuencia seleccionada del grupo que consiste de SEQ ID NO: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63 y 65. 2.- Un plásmido que comprende el polinucleótido de la reivindicación 1. 3.- El plásmido de la reivindicación 2 en donde dicho plásmido es un vector de expresión. 4.- Una célula que contiene el plásmido de la reivindicación 2. 5.- Una célula que contiene el plásmido de la reivindicación 3. 6.- Una composición inmunogénica que comprende el plásmido de la reivindicación 3. 7.- La composición de la vacuna para el tratamiento o la prevención de Brachyspira hyodysenteriae que comprende el vector de expresión de la reivindicación 3. 8.- La composición de la vacuna para el tratamiento o la prevención de Brachyspira hyodysenteriae que comprende la celda de la reivindicación 4. 9.- Una molécula de ADN que comprende una secuencia que es al menos 70% idéntica a la de los polinucleótidos de la reivindicación 1. 10.- Un plásmido que comprende el polinucleótido de la reivindicación 9.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2007/058049 WO2008017636A2 (en) | 2006-08-09 | 2007-08-03 | Genes and proteins of brachyspira hyodysenteriae and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6260101A2 true CO6260101A2 (es) | 2011-03-22 |
Family
ID=38667160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO10024772A CO6260101A2 (es) | 2007-08-03 | 2010-03-03 | Nuevos genes y proteinas de branchyspira hyodysenteriae y el uso de los mismos |
Country Status (11)
Country | Link |
---|---|
US (2) | US8992938B2 (es) |
EP (2) | EP2185578A2 (es) |
JP (1) | JP2010535030A (es) |
KR (2) | KR20100080591A (es) |
CN (1) | CN101821284B (es) |
AU (2) | AU2007283667B2 (es) |
BR (1) | BRPI0721908A2 (es) |
CO (1) | CO6260101A2 (es) |
MX (1) | MX2010001381A (es) |
UA (1) | UA104714C2 (es) |
WO (1) | WO2008017636A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA104714C2 (ru) * | 2007-08-03 | 2014-03-11 | Боерингер Ингельхайм Ветмедика Гмбх | Выделенный полинуклеотид brachyspira hyodysenteriae, кодирующий полипептид, и его применение |
EP2363407A1 (en) * | 2008-02-28 | 2011-09-07 | Murdoch University | Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof |
AU2009227986C1 (en) * | 2008-03-27 | 2014-06-19 | Murdoch University | Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof |
AU2013360773B2 (en) | 2012-12-21 | 2018-04-05 | Boehringer Ingelheim Vetmedica Gmbh | Novel recombinant outer membrane proteins from Brachyspira hyodysenteriae and uses thereof |
US10188715B2 (en) | 2013-06-28 | 2019-01-29 | Aquilon Cyl Sociedad Limitada | Swine dysentery vaccine |
EP3107864A4 (en) * | 2014-02-17 | 2018-02-28 | William Marsh Rice University | Laser induced graphene materials and their use in electronic devices |
JP2019500884A (ja) * | 2016-01-07 | 2019-01-17 | ウニベルシテイト ヘント | ブラキスピラ・ヒオディセンテリアのワクチン株 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3654090A (en) | 1968-09-24 | 1972-04-04 | Organon | Method for the determination of antigens and antibodies |
USRE31006E (en) | 1968-09-24 | 1982-08-03 | Akzona Incorporated | Process for the demonstration and determination of reaction components having specific binding affinity for each other |
NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US4016043A (en) | 1975-09-04 | 1977-04-05 | Akzona Incorporated | Enzymatic immunological method for the determination of antigens and antibodies |
US4491632A (en) | 1979-10-22 | 1985-01-01 | The Massachusetts General Hospital | Process for producing antibodies to hepatitis virus and cell lines therefor |
US4444887A (en) | 1979-12-10 | 1984-04-24 | Sloan-Kettering Institute | Process for making human antibody producing B-lymphocytes |
US4342566A (en) | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
EP0043718B1 (en) | 1980-07-07 | 1984-11-28 | National Research Development Corporation | Improvements in or relating to cell lines |
US4341761A (en) | 1980-07-25 | 1982-07-27 | E. I. Du Pont De Nemours And Company | Antibodies to immunogenic peptides and their use to purify human fibroblast interferon |
US4466917A (en) | 1981-02-12 | 1984-08-21 | New York University | Malaria vaccine |
US4493890A (en) | 1981-03-23 | 1985-01-15 | Miles Laboratories, Inc. | Activated apoglucose oxidase and its use in specific binding assays |
US4451570A (en) | 1981-03-26 | 1984-05-29 | The Regents Of The University Of California | Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line |
US4399121A (en) | 1981-11-04 | 1983-08-16 | Miles Laboratories, Inc. | Iodothyronine immunogens and antibodies |
US4427783A (en) | 1981-12-14 | 1984-01-24 | Hoffmann-La Roche Inc. | Immunoassay of thymosin α1 |
GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
CA1319101C (en) | 1986-09-03 | 1993-06-15 | Marta Iris Sabara | Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US6673776B1 (en) | 1989-03-21 | 2004-01-06 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
JPH05502370A (ja) * | 1989-09-13 | 1993-04-28 | エムエル テクノロジー ヴェンチャーズ エル.ピー. | 分子量39kDaの赤痢病原体抗原およびそれに対する遺伝子暗号付与 |
ZA918426B (en) | 1990-10-31 | 1992-12-30 | Akzo Nv | Chicken anemia virus vaccine and diagnostic |
EP0486106A3 (en) | 1990-11-16 | 1992-12-23 | Akzo N.V. | Marek's disease virus vaccine |
US5612487A (en) | 1991-08-26 | 1997-03-18 | Edible Vaccines, Inc. | Anti-viral vaccines expressed in plants |
US6034298A (en) | 1991-08-26 | 2000-03-07 | Prodigene, Inc. | Vaccines expressed in plants |
US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
US5712118A (en) | 1993-09-29 | 1998-01-27 | Research Foundation Of State University Of New York | Vaccine for branhamella catarrhalis |
US6150170A (en) | 1998-05-03 | 2000-11-21 | University Of Maryland At Baltimore | Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same |
US6682729B1 (en) | 1995-05-03 | 2004-01-27 | University Of Maryland, Baltimore | Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same |
US5877159A (en) | 1995-05-03 | 1999-03-02 | University Of Maryland At Baltimore | Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same |
US5824538A (en) | 1995-09-06 | 1998-10-20 | The United States Of America As Represented By The Secretary Of The Army | Shigella vector for delivering DNA to a mammalian cell |
AU750106B2 (en) | 1997-10-07 | 2002-07-11 | University Of Maryland Biotechnology Institute | Method for introducing and expressing RNA in animal cells |
EP1159414A4 (en) | 1999-09-24 | 2003-08-27 | Cyto Pulse Sciences Inc | METHOD FOR PROMOTING ELECTRICALLY ASSISTED ADMINISTRATION OF BIOLOGICAL MATERIALS IN CELLS |
AU2001240109A1 (en) | 2000-03-07 | 2001-09-17 | U.S. Army Medical Research Institute Of Infectious Diseases | Dna vaccines against poxviruses |
WO2001068889A2 (en) | 2000-03-16 | 2001-09-20 | Malone Robert W | Method for gene transfection and vaccination through skin using electropermeabilization |
EP1506297A2 (en) * | 2002-05-08 | 2005-02-16 | Akzo Nobel N.V. | Brachyspira hyodysenteriae vaccine |
AU2003250057B2 (en) * | 2002-07-17 | 2008-02-14 | Intervet International B.V. | Brachyspira hyodysenteriae vaccine |
AU2002953431A0 (en) * | 2002-12-19 | 2003-01-09 | Murdoch University | BmpB Novel Nucleotide and Amino Acid Sequences and Diagnostic and Therapeutic Uses Thereof |
US7531176B2 (en) * | 2003-12-19 | 2009-05-12 | David J Hampson | Brachyspira pilosicoli 72 kDa outer-membrane protein and diagnostic and therapeutic uses thereof |
US8834891B2 (en) * | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
EP1882035A2 (en) * | 2005-05-12 | 2008-01-30 | Novartis AG | Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy |
WO2007107323A2 (en) * | 2006-03-20 | 2007-09-27 | Novartis Ag | Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy |
UA104714C2 (ru) * | 2007-08-03 | 2014-03-11 | Боерингер Ингельхайм Ветмедика Гмбх | Выделенный полинуклеотид brachyspira hyodysenteriae, кодирующий полипептид, и его применение |
EP2363407A1 (en) * | 2008-02-28 | 2011-09-07 | Murdoch University | Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof |
AU2009227986C1 (en) * | 2008-03-27 | 2014-06-19 | Murdoch University | Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof |
AU2009316239B2 (en) * | 2008-11-14 | 2017-10-19 | Murdoch University | Vaccine strains of Brachyspira hyodysenteriae |
-
2007
- 2007-08-03 UA UAA201002402A patent/UA104714C2/ru unknown
- 2007-08-03 BR BRPI0721908-3A2A patent/BRPI0721908A2/pt not_active IP Right Cessation
- 2007-08-03 CN CN200780100937.4A patent/CN101821284B/zh not_active Expired - Fee Related
- 2007-08-03 WO PCT/EP2007/058049 patent/WO2008017636A2/en active Application Filing
- 2007-08-03 US US12/672,054 patent/US8992938B2/en not_active Expired - Fee Related
- 2007-08-03 EP EP07788187A patent/EP2185578A2/en not_active Withdrawn
- 2007-08-03 KR KR1020107004654A patent/KR20100080591A/ko active IP Right Grant
- 2007-08-03 MX MX2010001381A patent/MX2010001381A/es active IP Right Grant
- 2007-08-03 AU AU2007283667A patent/AU2007283667B2/en not_active Ceased
- 2007-08-03 KR KR1020147025966A patent/KR20140120946A/ko not_active Application Discontinuation
- 2007-08-03 EP EP15169456.9A patent/EP3018139A3/en not_active Withdrawn
- 2007-08-03 JP JP2010519342A patent/JP2010535030A/ja active Pending
-
2010
- 2010-03-03 CO CO10024772A patent/CO6260101A2/es not_active Application Discontinuation
-
2014
- 2014-08-13 AU AU2014213506A patent/AU2014213506A1/en not_active Abandoned
-
2015
- 2015-03-30 US US14/673,480 patent/US20160052974A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20160052974A1 (en) | 2016-02-25 |
EP3018139A3 (en) | 2016-08-10 |
BRPI0721908A2 (pt) | 2014-02-25 |
EP2185578A2 (en) | 2010-05-19 |
AU2007283667B2 (en) | 2014-09-04 |
KR20140120946A (ko) | 2014-10-14 |
EP3018139A2 (en) | 2016-05-11 |
WO2008017636A3 (en) | 2008-04-17 |
AU2007283667A1 (en) | 2008-02-14 |
US8992938B2 (en) | 2015-03-31 |
WO2008017636A2 (en) | 2008-02-14 |
UA104714C2 (ru) | 2014-03-11 |
KR20100080591A (ko) | 2010-07-09 |
JP2010535030A (ja) | 2010-11-18 |
CN101821284B (zh) | 2014-11-19 |
US20110020383A1 (en) | 2011-01-27 |
CN101821284A (zh) | 2010-09-01 |
MX2010001381A (es) | 2010-09-14 |
AU2014213506A1 (en) | 2014-09-04 |
WO2008017636A8 (en) | 2009-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6260101A2 (es) | Nuevos genes y proteinas de branchyspira hyodysenteriae y el uso de los mismos | |
CL2018000537A1 (es) | Anticuerpo anti-factor d del complemento; polinucleótido codificante; vector que comprende dicho polinucleótido; célula húesped que comprende dicho vector; método de fabricación de anticuerpo; composición farmacéutica que lo comprende; uso del anticuerpo para tratar trastornos inflamatorios o trastornos oculares (divisional de cl 1001-2009). | |
CL2020000252A1 (es) | Muteínas de interleucina 21 y métodos de tratamiento. | |
AR074397A1 (es) | Polipéptidos receptores de activina iib estabilizados y usos de los mismos | |
CL2019002167A1 (es) | Compuesto de la fórmula (ic) o una sal farmacéuticamente aceptable del mismo, o una composición farmacéutica que comprende dicho compuesto o una sal farmacéuticamente aceptable del mismo, y al menos un portador farmacéuticamente aceptable, y su uso en el tratamiento de disautonomía familiar al mejorar el empalme de marn. (divisional solicitud 201701823.) | |
AR049014A1 (es) | Mimeticuerpos de glp-1 humanos , composiciones y usos | |
CO6400155A2 (es) | Gen de delta-endotoxina axmi-150 y métodos de uso del mismo | |
AR080200A1 (es) | Genes delta-endotoxinicos axmi221z, axmi222z, axmi223z, axmi224z, y axmi225z y metodos para su uso | |
AR075818A1 (es) | Axmi-001, axmi- 002, axmi-030 y axmi -035 y axmi -045: genes de toxina y metodos para su uso | |
AR083839A1 (es) | Virus del sindrome reproductivo y respiratorio porcino (prrs) de los estados unidos y sus usos | |
BR112014008700A2 (pt) | composições úteis no tratamento de nefropatia e processos para preparação das mesmas | |
UY29639A1 (es) | Amidas sustituidas con heteroarilo que comprenden un grupo enlazador insaturado o cíclico, y su uso como productos farmacéuticos | |
AR079114A1 (es) | Proteinas de enlace de antigenos anti-orai1 y usos de las mismas | |
AR053385A1 (es) | Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia | |
BR112014001978A2 (pt) | proteínas variantes axmi205 e métodos para a utilização das mesmas | |
RU2017126566A (ru) | ВСТРЕЧАЮЩИЕСЯ В ПРИРОДЕ миРНК ДЛЯ КОНТРОЛИРОВАНИЯ ЭКСПРЕССИИ ГЕНОВ И ИХ ПРИМЕНЕНИЕ | |
AR053372A1 (es) | Proteinas inmunologicas de lawsonia intracellularis | |
RU2015119523A (ru) | Новый способ лечения повреждения спинного мозга с применением фрагмента hmgb1 | |
ES2491565T3 (es) | Agente de transfección | |
AR069573A1 (es) | Promotores de proteinas quimericas y ricas en prolina para la expresion en plantas, donde el fenotipo es una menor infeccion por patogenos | |
PE20141549A1 (es) | VARIANTES DE CRIg MADURAS POR AFINIDAD | |
AR073967A1 (es) | Peptido-epitope rab6kifl/kif20a y vacunas que contienen al mismo | |
WO2007107323A8 (en) | Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy | |
CO6311109A2 (es) | Nuevas secuencias de la brachyspira composiciones inmunogenicas metodos para la preparacion y su uso | |
TW200740997A (en) | Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |